Mammograms in cosmetic breast surgery

ABSTRACT

Mammograms are necessary as preoperative preparation for breast surgery in certain patients. There is a definite need for mammograms preoperatively in patients over 40 who should be obtaining mammograms on an annual basis. Under the age of 40 mammograms are up to the discretion of the surgeon. Postoperative mammograms should be obtained as a baseline 6-12 months after breast surgery.

KEYWORDS

Mammograms - Cosmetic Surgery - Breast

• 1 Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, Sener S, Saslow D, Eyre HJ. American Cancer Society guidelines for the early detectionof cancer. CA - A Cancer J Clin 2002; 52: 8-22
• 2 Jemal A, Thomas A, Murray T, Than M. Cancer statistics, 2002. CA - Cancer J Clin 2002; 52: 23-47
• 3 Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003; 53: 5-26
• 4 Durso EA. Carcinoma arising in fibroadenoma: A case report. Radiology 1972; 102: 565
• 5 Buzonowsaki-Konakry K, Harrison EG, Payne WS. Lobular carcinoma arising in fibroadenoma of the breast. Cancer 1975; 35: 450-6
• 7 Pick PW, Iossifides IA. Occurrence of breast carcinoma within a fibroadenoma. A review. Arch Pathol Lab Med 1984; 108: 590-4
• 8 Schnitt SJ, Connolly JL. Pathology of benign breast disorders. In : Harris JR. editor Diseases of the Breast. 2nd. edn Philadelphia: Williams & Wilkins; 2000: p.75-93
• 9 Botta PG, Cosimi MF. Breast lobular carcinoma in a fibroadenoma of the breast. Eur J Surg Pathol 1985; 11: 283-5
• 10 Diaz NM, Palmer JO, McDivitt RW. Carcinoma arising within fibroadenomas of the breast. A clinicopathologic study of 105 patients. Am J Clin Path 1991; 95: 614-22
• 11 Tabbane F, el May A Hachiche M, Bahi J, Jaziri M, Cammoun M, Mourali N. Breast cancer in women under 30 years of age. Breast Cancer Res Treat 1985; 6: 137-44
• 12 Silverstein HJ, Handel N, Gamagami P, Waisman JR, Gierson ED, Rosser RJ. Breast cancer in women after augmentation mammoplasty. Arch Surg 1988; 123: 681-5
• 13 Peters W, Smith D, Lugowski S, Pritzker K, Holmyard D. Calcification properties of saline-filled implants. Plast Reconstr Surg 2001; 107: 356-63
• 14 Peters W, Pritzker K, Smith D, Fornasier V, Holmyard D, Lugowski S. Capsular calcification associated with silicone breast implants:incidence, determinants, and characterization. Ann Plast Surg 1998; 41: 348-60
• 15 Peter W, Smith D. Calcification of breast implant capsules:incidence, diagnosis, and contributing factors. 1995; 34: 8-11
• 16 Schmidt GH. Calcification bonded to saline-filled implants. Plast Reconstr Surg 1993; 92: 1423-5
• 17 Young VL, Bartell T, Destouet JM, Monsees B, Logan SE. Calcification of breast implant capsule. South Med J 1989; 82: 1171-3
• 18 Nicoletis C, Wlodarczyk B. A rare complication of breast prosthesis:Calcification of the periprosthetic retractile capsule. Ann Chir Plast Esthet 1983; 28: 388-9
• 19 Fulton JE. Breast contouring with "gelled" autologous fat:A 10-year update. Int J Cosm Surg Aesthet Derm 2003; 5: 155-63
• 20 Rocek V, Rehulka M, Vojacek K, Kral V. Fat necrosis of the breasts with ring calcification. Acta Univ Palacki Olomuc Fac Med 1982; 102: 143-7
• 21 Kinoshita T, Yashiro N, Yoshigi J, Ihara N, Narita M. Fat necrosis of breast:a potential pitfall in breast MRI. Clin Imagine 2002; 26: 250-53
• 22 Kurtz B, Achten C, Audretsch W, Rezai M, Zocholl G. MR mammography of fatty tissue necrosis. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verhfahr 1996; 165: 359-63
• 23 Bilgen IG, Ustum EE, Memis A. Fat necrosis of the breast:clinical, mammographic, and sonographic features. Eur J Radiol 2001; 39: 92-9
• 24 Baber CE, Libshitz HI. Bilateral fat necrosis of the breast following reduction mammoplasties. Am J Roent 1977; 128: 508-9
• 25 Miller CL, Feig SA, Fox JW. Mammographic changes in reduction mammoplasty. Am J Roent 1987; 149: 35-8
• 26 Brown FE, Sargent SK, Cohen SR, Morain WD. Mammographic changes following reduction mammaplasty. Plast Reconstr Surg 1987; 80: 91-8
• 27 Abboud M, Vadoud-Seyedi J, De A, Cukierfajn M, Lejour M. Incidence of calcifications in the breast after surgical reduction and liposuction. Plast Reconstr Surg 1995; 96: 620-6
• 28 Di Giuseppe A.. Ultrasound-assisted liposuction for breast reduction. In : Shiffman MA, Giuseppe Di A. editors Textbook of Liposuction: Principles and Practice. Marcel Dekker; 2004
• 29 Lejour M, Abboud M. Vertical mammoplasty without inframammary scar and with liposuction. Perspect Plast Surg 1990; 4: 67
• 30 Lejour M.. Reduction of large breasts by a combination of liposuction and vertical mammoplasty. In : editor Master of Surgery:Plastic and Reconstructive Surgery. Boston, Little, Brown; 1994
• 31 Jackson R. Personal communication. 2003
• 32 Perras C.. Fifteen years of mammography in cosmetic surgery of the breast. Aesthetic Plast Surg 1990; 14: 81-4
• 33 Lind DS, Copeland EM. III: Local recurrence, the augmented breast, and the contralateral breast. In :. Bland KI, Copeland EM. III, editors The Breast:Comprehensive Management of Benign and Malignant Diseases. 2nd. edn Philadelphia: W.B. Saunders Company; 1998: p1421-32
• 34 Eklund GW, Busby RC, Miiller SH, Job JS. Improved Imaging of the augmented breast. Am J Roentgenol 1988; 151: 469-73
• 35 Taucher S, Gnant M, Jekesz R. Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene. Langenbecks Arch Surg 2003; 388: 3-8
• 36 Winer EP, Morrow M, Osborne CK, Harris JR. Malignant tumors of the breast. In : DeVita VT, Hellman S, Rosenberg SA. editors Cancer: Principles & Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2001: p.1651-717
• 37 Ford D, Easton D, Bishop Narod SA, Goldgar DE. Risks of cancer in BRCA1 mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343: 692-5
• 38 Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M. The risk of cancer associated with specific mutations of BRCA1 and BRCA2:among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8
• 39 Grann VR, Panegeas KS, Whang W, Antman KH, Neugut AI. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol 1998; 16: 979-85